Halozyme · Health Care
HALO
$77.81
Halozyme Therapeutics, Inc. is an American biotechnology company.HalozymeTherapeutics,Inc.是一家美国生物技术公司。
Secular growth长期成长
Mid cap中盘
$9B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
Key Statistics关键统计
Price价格
$77.81
4.6% below 52-week high低于52周高点 4.6%
Market Cap市值
$9B
Normal volume正常成交量
P/E Ratio市盈率
28.9x
28.9x sector median
Beta贝塔
0.56
Moves about 0.6x the market波动幅度约为市场的 0.6 倍
RSI (14)RSI（14）
59
Neutral zone中性区域
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
47th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
11.2% of float
Performance价格表现
| Period周期 | HALO | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +2.1% | -1.5% | Beat the index by 3.6 points跑赢指数 3.6 个百分点 |
| 1 Month近1月 | +13.5% | +0.6% | Beat the index by 12.9 points跑赢指数 12.9 个百分点 |
| 3 Months近3月 | +12.3% | +4.7% | Beat the index by 7.6 points跑赢指数 7.6 个百分点 |
| 6 Months近6月 | +9.3% | +7.8% | Beat the index by 1.5 points跑赢指数 1.5 个百分点 |
| Year to date年初至今 | +10.7% | +9.1% | Beat the index by 1.6 points跑赢指数 1.6 个百分点 |
| 1 Year近1年 | +34.6% | +19.4% | Beat the index by 15.2 points跑赢指数 15.2 个百分点 |
| 3 Years近3年 | +86.6% | +69.4% | Beat the index by 17.2 points跑赢指数 17.2 个百分点 |
Technicals技术面
RSI (14)RSI（14）
59
Neutral zone中性区域
vs 50-day相对50日均线
+8.6% vs 50-day avg
vs 200-day相对200日均线
+12.4% vs 200-day avg
Volatility rank波动率分位
47th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$76.83
Don't chase above不追高于
$78.60
Stop止损
$68.55
Buy soon — on confirmation即将买入 — 待确认
Earnings财务业绩
16
days until next report天后公布财报
2026-08-04
Estimates roughly stable预期基本稳定
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | HALO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 28.92x | 28.92 | 50% |
| P/B市净率 | 187.75x | 3.52 | 0% |
| P/S市销率 | 6.56x | 3.02 | 20% |
| Earnings yield盈利收益率 | 3.46% | 2.72 | 63% |
| FCF yield自由现金流收益率 | 7.03% | 3.94 | 83% |
| Shareholder yield股东收益率 | 3.74% | 1.89 | 74% |
| EV/EBITDA企业价值/EBITDA | 23.26x | 18.21 | 35% |
| P/FCF市值/自由现金流 | 14.22x | 22.42 | 80% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 39.2%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 23.0%
Free Cash Flow自由现金流
Margins利润率
649.2%Return on Equity股本回报率
12.5%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 4.18 |
| Current ratio流动比率 | 4.66 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $51.6M |
| Share count change (1y)股数变化（1年） | -4.3% |
Piotroski皮奥特罗斯基 5/9
Altman Z阿尔特曼Z: safe (3.7)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 38% of its sector on blended multiples综合估值倍数低于行业内 38% 的公司
Beta市场敏感度
0.56×
0.21×3×
Moves about 0.6× the market波动幅度约为市场的 0.6 倍
Financial Health财务健康
5/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
HALO StochRSI turned up from oversoldHALO StochRSI自超卖区上行
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$19.7M net (0 buyers, 3 sellers)-$19.7M 净值（0 买家，3 卖家）
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 17, 2026
HALO StochRSI turned up from oversoldHALO StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $77.81.StochRSI重回20上方 — 下行动量趋缓的最早预警。$77.81。
Jul 16, 2026
HALO took relative-strength leadershipHALO 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $77.54.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$77.54。
Jul 13, 2026
HALO daily MACD crossed downHALO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $76.11.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$76.11。
Jul 7, 2026
HALO made a new 52-week highHALO 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $81.57.价格创出52周新高 — 全市场关注的动量/趋势极值。$81.57。
Jul 6, 2026
Golden cross on HALOHALO 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $80.78.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$80.78。
Jul 2, 2026
HALO RSI reached overboughtHALO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $79.45.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$79.45。
Jul 1, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Showing last 15 of显示最近15条，共 244 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.06
Value价值
-0.9
Quality质量
+1.0
Investment资本投入
-0.8
Shareholder payout股东回报
-0.1
Low volatility低波动
+0.5
Low market beta低市场敏感度
+0.4
Earnings quality盈利质量
+1.7
Short interest空头兴趣
-1.3
Company Profile公司档案
Halozyme Therapeutics, Inc. is an American biotechnology company.HalozymeTherapeutics,Inc.是一家美国生物技术公司。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
- Receivables stretch
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。